For: | Onat A, Aydın M, Can G, Köroğlu B, Karagöz A, Altay S. High adiponectin levels fail to protect against the risk of hypertension and, in women, against coronary disease: involvement in autoimmunity? World J Diabetes 2013; 4(5): 219-225 [PMID: 24147206 DOI: 10.4239/wjd.v4.i5.219] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v4/i5/219.htm |
Number | Citing Articles |
1 |
Ou Wu, Xi Lu, Jianhang Leng, Xingyu Zhang, Wei Liu, Fenfang Yang, Hu Zhang, Jiajia Li, Saber Khederzadeh, Xiaodong Liu, Chengda Yuan. Reevaluating Adiponectin’s impact on obesity hypertension: a Chinese case-control study. BMC Cardiovascular Disorders 2024; 24(1) doi: 10.1186/s12872-024-03865-4
|
2 |
E. Sklyarov, T. Maksymets. Risk Factors and Predictors of Ischemic Heart Disease Onset in Females. Lviv clinical bulletin 2013; 4(4): 52 doi: 10.25040/lkv2013.04.052
|
3 |
Jun Muratsu, Kei Kamide, Takashi Fujimoto, Yasushi Takeya, Ken Sugimoto, Yoshiaki Taniyama, Atsuyuki Morishima, Katsuhiko Sakaguchi, Yuji Matsuzawa, Hiromi Rakugi. The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples. Frontiers in Endocrinology 2022; 12 doi: 10.3389/fendo.2021.805244
|
4 |
Tatiana A. Brodskaya, Nina I. Repina, Vera A. Nevzorova, Natalia G. Plekhova, Valentin B. Shumatov. Aortic stiffness and content of adipokines in the serum in persons of European and South Asian ethnic. Terapevticheskii arkhiv 2021; 93(4): 397 doi: 10.26442/00403660.2021.04.200679
|
5 |
Altan Onat, İbrahim Dönmez, Yusuf Karadeniz, Hakan Çakır, Ayşem Kaya. Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity. Expert Review of Cardiovascular Therapy 2014; 12(6): 667 doi: 10.1586/14779072.2014.910114
|
6 |
Shishir Sharma, Laura A. Colangelo, Donald Lloyd-Jones, David R. Jacobs, Myron D. Gross, Samuel S. Gidding, Philip Greenland. Longitudinal associations between adiponectin and cardiac structure differ by hypertensive status: Coronary Artery Risk Development in Young Adults. Cardiovascular Endocrinology 2016; 5(2): 57 doi: 10.1097/XCE.0000000000000080
|
7 |
Shokei Kim-Mitsuyama, Hirofumi Soejima, Osamu Yasuda, Koichi Node, Hideaki Jinnouchi, Eiichiro Yamamoto, Taiji Sekigami, Hisao Ogawa, Kunihiko Matsui. Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trial. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52977-x
|
8 |
Poghni A. Peri‐Okonny, Colby Ayers, Naim Maalouf, Sandeep R. Das, James A. de Lemos, Jarett D. Berry, Aslan T. Turer, Ian J. Neeland, Philipp E. Scherer, Wanpen Vongpatanasin. Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart Study. Diabetes/Metabolism Research and Reviews 2017; 33(2) doi: 10.1002/dmrr.2840
|
9 |
Servet Altay, Altan Onat, Yusuf Karadeniz, Fatma Özpamuk-Karadeniz, Günay Can. Prediction by Low Plasma HbA1c of Mortality, Cardiac and Noncardiac Disease Risk: Modulation by Diabetic Status and Sex. Journal of Investigative Medicine 2015; 63(6): 821 doi: 10.1097/JIM.0000000000000216
|
10 |
Altan Onat, Evin Ademoglu, Yusuf Karadeniz, Gunay Can, Ahmet Okan Uzun, Barıs Simsek, Aysem Kaya. Population-based serum omentin-1 levels: paradoxical association with cardiometabolic disorders primarily in men. Biomarkers in Medicine 2018; 12(2): 141 doi: 10.2217/bmm-2017-0197
|